Related Experiment Video
Updated: Jan 30, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
Published on: April 28, 2019
CSF1R antagonism limits local restimulation of antiviral CD8+ T cells during viral encephalitis
Kristen E Funk1, Robyn S Klein2,3,4
1Department of Internal Medicine, Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, MO, 63110, USA.
Background:
Microglia are resident macrophages of the central nervous system (CNS) locally maintained through colony-stimulating factor 1 receptor (CSF1R) signaling. Microglial depletion via CSF1R inactivation improves cognition in mouse models of neuroinflammation, but limits virologic control in the CNS of mouse models of neurotropic infections by unknown mechanisms. We hypothesize that CSF1R plays a critical role in myeloid cell responses that restrict viral replication and locally restimulate recruited antiviral T cells within the CNS.
Methods:
The impact of CSF1R signaling during West Nile virus infection was assessed in vivo using a mouse model of neurotropic infection. Pharmacological inactivation of CSF1R was achieved using PLX5622 prior to infection with virulent or attenuated strains of West Nile virus (WNV), an emerging neuropathogen. The subsequent effect of CSF1R antagonism on virologic control was assessed by measuring mortality and viral titers in the CNS and peripheral organs. Immune responses were assessed by flow cytometric-based phenotypic analyses of both peripheral and CNS immune cells.
Results:
Mice treated with CSF1R antagonist prior to infection exhibited higher susceptibility to lethal WNV infection and lack of virologic control in both the CNS and periphery. CSFR1 antagonism reduced B7 co-stimulatory signals on peripheral and CNS antigen-presenting cells (APCs) by depleting CNS cellular sources, which limited local reactivation of CNS-infiltrating virus-specific T cells and reduced viral clearance.
Conclusions:
Our results demonstrate the impact of CSF1R antagonism on APC activation in the CNS and periphery and the importance of microglia in orchestrating the CNS immune response following neurotropic viral infection. These data will be an important consideration when assessing the benefit of CSF1R antagonism, which has been investigated as a therapeutic for neurodegenerative conditions, in which neuroinflammation is a contributing factor.
Insights
Inactivating colony-stimulating factor 1 receptor (CSF1R) impairs the immune system's ability to control West Nile virus (WNV) infection. This highlights the crucial role of microglia in antiviral defense within the central nervous system (CNS).
Area of Science:
- Neuroimmunology
- Virology
- Immunology
Background:
- Microglia, the CNS's resident macrophages, are maintained by CSF1R signaling.
- Microglial depletion via CSF1R inactivation improves cognition in neuroinflammation models but impairs viral control.
- The mechanisms by which CSF1R signaling impacts virologic control in neurotropic infections are unclear.
Purpose of the Study:
- To investigate the role of CSF1R signaling in myeloid cell responses during West Nile virus (WNV) infection.
- To determine the impact of CSF1R antagonism on viral replication and immune cell function within the CNS.
Main Methods:
- A mouse model of neurotropic WNV infection was used.
- Pharmacological inactivation of CSF1R was achieved using PLX5622 before infection.
- Virologic control, mortality, and immune cell phenotypes were assessed.
Main Results:
- CSF1R antagonism led to increased susceptibility to lethal WNV infection and impaired viral control in the CNS and periphery.
- CSF1R antagonism reduced co-stimulatory signals on antigen-presenting cells (APCs).
- This reduction limited T cell reactivation and viral clearance in the CNS.
Conclusions:
- CSF1R signaling is critical for APC activation and orchestrating CNS immune responses against neurotropic viral infections.
- Microglia play a vital role in restricting viral replication and promoting antiviral T cell responses.
- These findings are important for evaluating CSF1R antagonism as a therapeutic strategy, particularly in neurodegenerative diseases with neuroinflammation.
Related Concept Videos
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Limiting Reactant
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Viral Recombination
The Number e as a Limit
Viral Structure

